BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23548871)

  • 21. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erythrocytosis, renal artery stenosis and arterial hypertension in a kidney transplant recipient].
    Marinelli A; Della Grotta F
    G Ital Nefrol; 2010; 27(5):540-4. PubMed ID: 20922687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocytosis after renal allotransplantation: treatment by removal of the native kidneys.
    Dagher FJ; Ramos E; Erslev A; Karmi S; Alongi SV
    South Med J; 1980 Jul; 73(7):940-2. PubMed ID: 6992287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital erythrocytosis.
    McMullin MF
    Int J Lab Hematol; 2016 May; 38 Suppl 1():59-65. PubMed ID: 27161533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of anemia and erythrocytosis.
    Hodges VM; Rainey S; Lappin TR; Maxwell AP
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):139-58. PubMed ID: 17656101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic erythrocytosis in a patient on chronic hemodialysis.
    Lee DH; Min JH; Bae SB; Gil HW; Yang JO; Lee EY; Hong SY
    Kidney Res Clin Pract; 2015 Mar; 34(1):60-3. PubMed ID: 26484022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocytosis after renal transplantation. The response to theophylline treatment.
    Ilan Y; Dranitzki-Elhallel M; Rubinger D; Silver J; Popovtzer MM
    Transplantation; 1994 Mar; 57(5):661-4. PubMed ID: 8140628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of losartan on the treatment of posttransplant erythrocytosis.
    Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
    Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative erythrocytosis of patients with end stage renal failure undergoing CAPD.
    Altiparmak MR; Ataman R; Ozaras R; Tahan V; Aydin S; Uzun H; Serdengecti K; Soysal T
    Ren Fail; 2002 Jan; 24(1):29-35. PubMed ID: 11921696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttransplant erythrocytosis.
    Vlahakos DV; Marathias KP; Agroyannis B; Madias NE
    Kidney Int; 2003 Apr; 63(4):1187-94. PubMed ID: 12631334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.
    Randi ML; Bertozzi I; Cosi E; Santarossa C; Peroni E; Fabris F
    Ann Hematol; 2016 Jan; 95(2):233-7. PubMed ID: 26547864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocytosis after renal transplantation: review of 101 cases.
    Einollahi B; Lessan-Pezeshki M; Nafar M; Pour-Reza-Gholi F; Firouzan A; Farhangi F; Pourfarziani V
    Transplant Proc; 2005 Sep; 37(7):3101-2. PubMed ID: 16213319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis.
    Cotes PM; Doré CJ; Yin JA; Lewis SM; Messinezy M; Pearson TC; Reid C
    N Engl J Med; 1986 Jul; 315(5):283-7. PubMed ID: 3724821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early posttransplant erythrocytosis in renal allograft recipients.
    Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
    J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttransplant erythrocytosis: case report and review of newer treatment modalities.
    Perazella MA; Bia MJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1653-9. PubMed ID: 8318681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to manage polycythemia vera.
    Passamonti F
    Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism.
    Kozan P; Chalasani S; Handelsman DJ; Pike AH; Crawford BA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):12-7. PubMed ID: 24152686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
    Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and laboratory evaluation of the patient with erythrocytosis.
    Lee G; Arcasoy MO
    Eur J Intern Med; 2015 Jun; 26(5):297-302. PubMed ID: 25837692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.